Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBYOT.L Regulatory News (BYOT)

  • There is currently no data for BYOT

Test Protocol for Testing Anti-Viral Efficacy

26 Feb 2021 07:00

RNS Number : 4122Q
Byotrol PLC
26 February 2021
 

 

 

Byotrol Plc

("Byotrol" or the "Company")

 

Landmark test protocol for testing long-lasting anti-viral efficacy

 

 

Byotrol plc (AIM:BYOT), the specialist infection prevention and control company, is pleased to announce that it has developed and externally validated a new test for determining whether cleaning and sanitising products have long-lasting efficacy against viruses in real-life use.

· This new test determines whether sanitising and cleaning products offer any long-lasting protection against COVID-19

· Byotrol is now standing behind product efficacy claims supporting infection control products that offer 24-hour protection against viruses and bacteria in real-life conditions, where surfaces are frequently touched

· The Company believes that this new test could help minimise the spread of the virus when used in conjunction with the cleaning and sanitising of shops, schools and offices when they reopen

Byotrol has developed the new test in response to an increasing number of products claiming long-lasting efficacy against coronavirus, based on laboratory conditions which ignore the constant abrasion of surfaces in real-life environments (and which would then make many products ineffective).

 

Byotrol developed the industry standard test for long-lasting efficacy in real-life against bacteria and yeast in 2014 with the help of independent industry experts. The test, named PAS 2424:2014, was approved by the British Standards Institute (BSI) and is the only British standard to prove the efficacy of a disinfectant product over 24 hours. The PAS 2424:2014 test is currently being reviewed by the CEN Committee for approval as a new European EN test standard.

 

This new test for viruses simulates 'real-life' conditions by creating frequent abrasions on surfaces after products have been applied, to replicate frequent touching of surfaces throughout the day. The surfaces are then tested to see whether the product is still present and killing viruses. The test is limited to 24 hours, to ensure that the result is attributed to the efficacy of the product, not the length of time the virus has been left to dry out on a surface, which could result in a false positive.

 

This new test was performed internally in Byotrol's virology lab with the results being reviewed and validated externally by Professor James Stewart, Chair of Molecular Virology at the University of Liverpool, who commented: "A validation of the effectiveness of surface disinfectants against viruses using this test is an important step forward for the industry and consumers alike."

 

Byotrol plans to gain approval from the BSI again, to make this new test the British standard for proving the long-lasting efficacy of disinfectants against viruses.

 

The application of this test could help businesses and consumers select products which are proven to be effective in a variety of public spaces where surfaces are frequently touched, genuinely promoting public health.

 

 

 

Trevor Francis, Chief Technology Officer of Byotrol plc commented:

 

"Long-term surface protection against viruses is the holy grail that businesses in the hygiene sector are chasing currently. We have responded to a clear market need for clarity on which surface disinfectants continue to deactivate viruses in real-life environments and which don't. It's a huge win for consumers and the government as we return to normality beyond the pandemic."

 

 

Enquiries:

 

Byotrol plc

Trevor Francis - Chief Technology Officer

David Traynor - Chief Executive Officer

Nic Hellyer - Chief Financial Officer 01925 742 000

 

finnCap

Geoff Nash/Kate Bannatyne - Corporate Finance   020 7220 0500

Richard Chambers - ECM

 

Flagstaff Strategic and Investor Communications

Tim Thompson/Andrea Seymour/Fergus Mellon +44 (0)207 129 1474

byotrol@flagstaffcomms.com

 

 

 

 

 

Notes to Editors:

 

Byotrol plc (BYOT.L), quoted on AIM, is a specialist infection prevention and control company, operating globally in the Healthcare, Industrial, Food and Consumer sectors, providing low toxicity products with a broad-based and targeted efficacy across all microbial classes; bacteria, viruses (including coronavirus), fungi, moulds, mycobacteria and algae.

 

Byotrol's products can be used stand-alone or as ingredients within existing products, where they can significantly improve their performance, especially in personal hygiene, domestic and industrial disinfection, odour control, food production and food management.

 

Byotrol develops and commercialises technologies that create easier, safer and cleaner lives for everyone.

 

For more information, please go to byotrol.co.uk

 

 

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRABLGDDIXDDGBU
Date   Source Headline
23rd Aug 201811:30 amRNSFinal Results
1st Aug 20187:00 amRNSNotice of Results
17th May 20187:00 amRNSFirst US Retail Trial with Target
10th May 20184:32 pmRNSHolding(s) in Company
10th May 20187:00 amRNSState approval in US
23rd Apr 20183:07 pmRNSHolding(s) in Company
11th Apr 20187:00 amRNSTrading Statement
26th Feb 20183:10 pmRNSHolding(s) in Company
18th Jan 20187:00 amRNSDirector Dealing
14th Dec 20177:01 amRNSKey US Hire & Grant of Options
14th Dec 20177:00 amRNSInterim Results
7th Dec 20177:00 amRNSNotice of Results
10th Nov 20177:00 amRNSGrant of Options & Director/PDMR Shareholdings
28th Sep 201711:49 amRNSResult of AGM
6th Sep 201712:48 pmRNSHolding(s) in Company
6th Sep 201711:37 amRNSForm 8.3 - Byotrol Plc
6th Sep 201711:31 amRNSHolding(s) in Company
5th Sep 20174:37 pmRNSHolding(s) in Company
5th Sep 20174:36 pmRNSHolding(s) in Company
5th Sep 20174:35 pmRNSHolding(s) in Company
4th Sep 201711:57 amRNSResult of General Meeting
31st Aug 20177:00 amRNSResult of Open Offer
30th Aug 20179:24 amRNSPosting of Annual Report and Notice of AGM
29th Aug 20171:19 pmRNSConversion of Loan Notes and Issue of Equity
17th Aug 20172:31 pmRNSHolding(s) in Company
8th Aug 20174:47 pmRNSPlacing & Open Offer Timetable
7th Aug 20179:44 amRNSHolding(s) in Company
3rd Aug 201712:00 pmRNSResult of Proposed Fundraising
3rd Aug 20177:01 amRNSProposed Fundraising
3rd Aug 20177:00 amRNSFinal Results
13th Jun 20177:00 amRNSEPA Approval
13th Mar 20177:00 amRNSAcquisition
6th Feb 20177:00 amRNSDirector Dealing
1st Feb 20177:00 amRNSBoard changes and issue of options
13th Dec 20167:00 amRNSInterim Results
7th Dec 201612:29 pmRNSNotice of Interim Results
14th Oct 20167:00 amRNSGrant of Options and Director Shareholdings
12th Oct 20167:00 amRNSTransfer of Convertible Loan Notes
30th Sep 20163:16 pmRNSResult of Noteholders Meeting
22nd Sep 20164:51 pmRNSResult of AGM
9th Sep 20167:00 amRNSProposed Revision to Loan Notes
18th Aug 20167:00 amRNSFinal Results
8th Jul 20167:00 amRNSTrading Update and Notice of AGM
25th Feb 20167:00 amRNSTrading Statement
19th Feb 20163:34 pmRNSDirector/PDMR Shareholding
3rd Dec 20158:00 amRNSGrant of Options
3rd Dec 20157:00 amRNSInterim Results
9th Sep 201512:06 pmRNSHolding(s) in Company
8th Sep 20154:05 pmRNSResult of AGM and Completion of Placing
24th Aug 20151:57 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.